Martini Gregory S.
Chief Financial Officer
Martini Gregory S. has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 12, 2026.
On the most recent filing, Martini Gregory S. is listed as Chief Financial Officer at IRONWOOD PHARMACEUTICALS INC. Inside the rolling window, Martini Gregory S. reported no open-market purchases and 2 open-market sales totaling $82K in IRWD. The largest disclosed transaction in the window is a sale of 11,457 IRWD shares on Feb 24, 2026, worth $42K.
Companies traded
Other insiders at IRWD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$82K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Martini Gregory S. made?
Martini Gregory S. has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Martini Gregory S. trade?
Martini Gregory S. has filed SEC Form 4 disclosures for 1 company, including IRWD.
When was Martini Gregory S.'s most recent SEC Form 4 filing?
Martini Gregory S.'s most recent SEC Form 4 filing on Tracefour is dated Mar 12, 2026.
What is Martini Gregory S.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Martini Gregory S. is listed as Chief Financial Officer.
What is Martini Gregory S.'s total buy and sell value in the current window?
Inside the rolling retention window, Martini Gregory S. bought $0 and sold $82K based on SEC Form 4 filings.
What was Martini Gregory S.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 11,457 IRWD shares on 2026-02-24, worth $42K, per SEC Form 4 filings.